MedTrace Logo

AIMS Cancer Outcomes Study

NCT04495790 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-02-01

No results posted yet for this study

Summary

The overall aim is to describe disease-free survival (DFS) in early stage cancer patients and three-year overall survival (OS) outcomes in advanced stage cancer patients receiving Advanced Integrative Oncology (AIO) treatment in a prospective consecutive case series outcomes study. We will collect data and study outcomes for patients with cancer who receive care at AIMS Institute.

Conditions

Sponsors & Collaborators

  • Advanced Integrative Medical Science Institute

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-18
Primary Completion
2025-05-18
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495790 on ClinicalTrials.gov